Papaverine and Oxytocin vs Oxytocin Alone in Labor Induction
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorWestern Galilee Hospital-Nahariya
About this trial
This study aims to evaluate the efficacy and safety of combining papaverine with oxytocin for labor induction compared to oxytocin alone
Eligibility criteria
Qualifiers
Women with a singleton pregnancy Over the age of 18 Term (between 37-42 weeks of gestation) A medical decision for labor induction using oxytocin. Cephalic presentation Viable fetus nulliparity
Disqualifiers
parity >1
Twin pregnancy Women with a previous cesarean section Severe fetal anomalies Women with psychiatric disorders, including depression and schizophrenia. Contraindication to vaginal delivery Women unable to sign the consent form Women known to have SVT (supraventricular tachycardia). Women with a heart rate over 100 or arrhythmia Known sensitivity to any component of the drug Liver disease
Trial design
Treatments tested in this trial
- Papaverine
- normal saline
Treatment groups
126 Participants
are divided into 2 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
Western Galilee Hospital-Nahariya
Lead sponsor
Source ClinicalTrials.gov